Enbrel 50 MG/ML sureclickml
Ended Awarded
- Contract number
- SPE2DR26FK254
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,379
Award facts
- Contract value 100% obligated
- $34,379.03 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp was awarded a delivery order valued at $34,379.03 by the Defense Logistics Agency (DLA) on November 5, 2025, for the supply of Enbrel 50 mg/ml SureClick auto-injector pens. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of November 6, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 through December 2026.
AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, serves as a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency and military healthcare systems. This delivery order for Enbrel, a biologic immunosuppressant used to treat rheumatoid arthritis and other autoimmune conditions, reflects the contractor's ongoing role in supplying specialty pharmaceutical products to support federal medical supply chains. The award demonstrates the contractor's capability to meet federal procurement requirements through competitive processes, consistent with its extensive portfolio of federal medical supply contracts across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FK254?
SPE2DR26FK254 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 5, 2025.
How much is contract SPE2DR26FK254 worth?
The government has obligated $34,379 on SPE2DR26FK254.
Is contract SPE2DR26FK254 an order under another contract?
Yes. SPE2DR26FK254 is a delivery order under SPE2DR25D1104, an indefinite delivery contract.
Was contract SPE2DR26FK254 competed?
The extent of competition for SPE2DR26FK254 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award